Keyphrases
Trypanosoma Brucei
100%
Visceral Leishmaniasis
72%
N-myristoyltransferase
52%
N-Myristoyltransferase Inhibitors
49%
Human African Trypanosomiasis
45%
Trypanosoma Cruzi (T. cruzi)
42%
Trypanothione Synthetase
39%
Preclinical Candidate
30%
Drug Target
30%
Mouse Model
27%
Pyrazolo
26%
Chagas Disease
26%
Infectious Diseases
26%
Mycobacterium Tuberculosis (M. tb)
26%
Leishmania Donovani
25%
T. Brucei
24%
In Vivo Efficacy
23%
Phenotypic Screening
22%
Pyrazole Sulfonamides
21%
Drug Discovery
21%
Scaffold Hopping
21%
Central Nervous System
19%
Proteasome Inhibition
17%
Active Compounds
17%
Mode of Action
16%
Global Health
16%
Protozoan Parasites
16%
Amidase
16%
Penetrant
15%
Bifunctional
15%
Glutathione
15%
Synthetase
15%
Small Molecule Inhibitors
15%
Trypanothione
14%
Molecular Targets
13%
Healthcare Professionals
13%
Inhibitor Identification
13%
Pyrimidine
13%
Disease Burden
13%
Faculty Staff
13%
Antileishmanial Activity
13%
Building Knowledge
13%
Target Programs
13%
External Support
13%
Primary Level
13%
Developing World
13%
Social Capital
13%
Distance Learning
13%
Educational Opportunity
13%
Educators
13%
Pharmacology, Toxicology and Pharmaceutical Science
Trypanosoma Brucei
96%
Visceral Leishmaniasis
72%
Synthetase
52%
African Trypanosomiasis
43%
Trypanosoma Cruzi
42%
Trypanothione
39%
Infection
38%
Disease
35%
Chagas Disease
32%
Sulfonamide
30%
Hexachlorophene
29%
Structure Activity Relationship
28%
Carboxamide
26%
Mycobacterium Tuberculosis
26%
Pyrazole
24%
Mouse Model
24%
Drug Discovery
19%
Proteasome
17%
Amidase
16%
Drug Metabolism
15%
Leishmania donovani
15%
Leishmania Major
15%
Pharmacokinetics
15%
Trypanosomatidae
14%
Glutathione
14%
Parasitosis
14%
Protozoon
14%
Proteasome Inhibitor
13%
Chemotherapy
13%
Trypanosomiasis
13%
Naphthyridine Derivative
13%
Acyltransferase
13%
Hydroxamic Acid
13%
Amitrole
13%
Pyrimidine Derivative
13%
Dihydrofolate Reductase
13%
Cytochrome C
13%
Cysteine
13%
Oxidoreductase
13%
Protein Kinases
13%
Pteridine
13%
Indole
13%
Tryptophan
13%
Cytochrome B
13%
Transferase Inhibitor
13%
Target Activity
12%
Molecular Target
12%
Blood-Brain Barrier
10%
Tropical Disease
9%
Pharmaceutical Chemistry
8%